Resurgent Financial Advisors LLC Stryker Corp Transaction History

Resurgent Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$253.85 - $299.46 $507 - $598	-2 Reduced 0.81%	244 $73,000
Q3 2023 Nov 13, 2023	SELL	$266.54 - $302.43 $5,330 - $6,048	-20 Reduced 7.52%	246 $67,000
Q2 2023 Aug 14, 2023	SELL	$271.49 - $305.09 $16,289 - $18,305	-60 Reduced 18.4%	266 $81,000
Q1 2023 May 15, 2023	SELL	$246.13 - $285.47 $77,284 - $89,637	-314 Reduced 49.06%	326 $93,000
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $131,526 - $162,515	640 New	640 $156,000

2,230

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resurgent Financial Advisors LLC with notifications on news.